Page 985«..1020..984985986987..9901,000..»

Voyager Therapeutics Announces Fourth Quarter and Full Year 2019 Financial Results and Corporate Updates – Yahoo Finance

Posted: Published on March 5th, 2020

Protocol amendment being implemented for ongoing RESTORE-1 trial of VY-AADC (NBIb-1817) for Parkinsons disease; plan to initiate RESTORE-2 trial in 2H 2020 Update on VY-HTT01 for Huntingtons disease preclinical program expected in 2Q 2020 Strong financial position with ~$282M of cash at the end of 2019 and expected runway into mid-2022 CAMBRIDGE, Mass., March 03, 2020 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today reported its fourth quarter and full year 2019 financial results, program progress and corporate updates. In 2019, we took important steps toward our vision of establishing Voyager as the leader in neurological gene therapy, including forming our strategic collaboration with Neurocrine Biosciences, expanding our partnership with AbbVie, and further progressing our wholly-owned and partnered programs, said Andre Turenne, President and CEO of Voyager. Continue reading

Posted in Parkinson's Treatment | Comments Off on Voyager Therapeutics Announces Fourth Quarter and Full Year 2019 Financial Results and Corporate Updates – Yahoo Finance

BioVentrix Announces Ralph Stephan von Bardeleben, MD, as Co- Principal Investigator of the REVIVE-HF Clinical Trial – Yahoo Finance

Posted: Published on March 5th, 2020

REVIVE-HF seeks to demonstrate superiority of the Revivent TC System to current guideline treatment for heart failure BioVentrix, Inc., developer of the first transcatheter device for left ventricular remodeling after a heart attack, today announced that Ralph Stephan von Bardeleben, MD, of the University Medical Center of Mainz (Germany) has joined the European REVIVE-HF clinical trial of the Revivent TC Transcatheter Ventricular Enhancement System as co-principal investigator. Continue reading

Posted in Ventricular Remodeling | Comments Off on BioVentrix Announces Ralph Stephan von Bardeleben, MD, as Co- Principal Investigator of the REVIVE-HF Clinical Trial – Yahoo Finance

Systemic Sclerosis Myocarditis Associated With Higher Degrees of Myocardial Fibrosis – The Cardiology Advisor

Posted: Published on March 4th, 2020

Systemic sclerosis (SSc) myocarditis was found to occur more frequently in individuals with heart failure and a higher dyspnea class; SSc-myocarditis was also found to be associated with higher degrees of myocardial fibrosis, according to study results published in Rheumatology. According to the researchers, a comprehensive description and distinctive representation of SSc myocarditis is currently lacking, but it is needed to accurately identify the disease in its early stages to initiate therapy Continue reading

Posted in Clinical Cardiology | Comments Off on Systemic Sclerosis Myocarditis Associated With Higher Degrees of Myocardial Fibrosis – The Cardiology Advisor

Study Assesses the Prevalence of Clinically Relevant Aortic Dilatation in Aging Masters-Level Athletes – DocWire News

Posted: Published on March 4th, 2020

A new study highlighted the relationship between ascending aortic dilatation and long-term endurance exercise in aging masters-level athletes. Continue reading

Posted in Clinical Cardiology | Comments Off on Study Assesses the Prevalence of Clinically Relevant Aortic Dilatation in Aging Masters-Level Athletes – DocWire News

Europe deserves more and better research & innovation in cardiovascular disease – Open Access Government

Posted: Published on March 4th, 2020

Europe has a history of strong biomedical heart research and impactful clinical studies, which have resulted in improving cardiovascular health. Despite a period of decline in cardiovascular-related mortality thanks to the introduction of new treatments and prevention measures, cardiovascular disease (CVD) is levelling off and remains the leading cause of death worldwide and a major burden to society. Worryingly, there is a wrong perception that prevention is sufficient to tackle the burden of CVD Continue reading

Posted in Clinical Cardiology | Comments Off on Europe deserves more and better research & innovation in cardiovascular disease – Open Access Government

Neovasc Reducer Featured in Peer Reviewed EuroIntervention and PCR Online – BioSpace

Posted: Published on March 4th, 2020

VANCOUVER, March 03, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc Inc.("Neovasc" or the "Company") (NASDAQ,TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and minimally invasive devices for the treatment of refractory angina, announced today the Neovasc Reducer (the "Reducer") was featured in the peer reviewed publicationEuroIntervention, the official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and highlighted inPCR Online. Continue reading

Posted in Clinical Cardiology | Comments Off on Neovasc Reducer Featured in Peer Reviewed EuroIntervention and PCR Online – BioSpace

Advanced imaging tools transforming Heart Care – ETHealthworld.com

Posted: Published on March 4th, 2020

New Delhi: Turning a corner in interventional cardiology, advanced tools have opened new frontiers in heart care. Continue reading

Posted in Clinical Cardiology | Comments Off on Advanced imaging tools transforming Heart Care – ETHealthworld.com

Acute Aortic Dissection Detection Risk Score Found to Have High Sensitivity – The Cardiology Advisor

Posted: Published on March 4th, 2020

The acute aortic dissection detection risk score (ADD-RS), used alone or in combination with dimerized plasmin fragment D (D-dimer) was found to rule acute aortic syndrome (AAS) with high sensitivity, according to a systematic review and meta-analysis published inEuropean Heart Journal: Acute Cardiovascular Care. The investigators searched Cochrane Controlled Register of Trials, Embase, and MEDLINE, up to December 2018 for studies in which the accuracy of ADD-RS was examined. Two authors independently assessed selected studies for eligibility, and examined data on: patient demographics, sample size, study characteristics number of cases and controls, study setting methodological quality, ADD-RS cut-off value, D-dimer cutoff value (if appropriate), types of reference tests, and sensitivity and specificity Continue reading

Posted in Clinical Cardiology | Comments Off on Acute Aortic Dissection Detection Risk Score Found to Have High Sensitivity – The Cardiology Advisor

Itamar Medical and Clalit Research Institute Establish Research Collaboration to Explore WatchPAT Signals’ Ability to Predict Health Outcomes Using…

Posted: Published on March 4th, 2020

CAESAREA, Israel, March 02, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, today announced that it has entered into a research collaboration agreement with Clalit Research Institute (CRI), a subsidiary of Clalit Health Services (CHS), Israels largest state-mandated health service organization. Continue reading

Posted in Clinical Cardiology | Comments Off on Itamar Medical and Clalit Research Institute Establish Research Collaboration to Explore WatchPAT Signals’ Ability to Predict Health Outcomes Using…

Promising New Treatments for Multiple Sclerosis

Posted: Published on March 4th, 2020

Multiple sclerosis (MS) is a chronic disease that affects the central nervous system. Continue reading

Posted in MS Treatment | Comments Off on Promising New Treatments for Multiple Sclerosis

Page 985«..1020..984985986987..9901,000..»